Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2001, p. 690-694, Vol. 8, No. 4
Departments of
Pediatrics,1
Pathology,2
Biometry,3 and
Medicine,4 Louisiana State University
Health Sciences Center, Shreveport, Louisiana
Received 8 September 2000/Returned for modification 22 January
2001/Accepted 13 March 2001
A better understanding of how human immunodeficiency virus (HIV)
coinfection affects the course of hepatitis C virus (HCV) infection is
required to select patients with HIV who would benefit from current HCV
therapy. Between June 1996 and March 2000, HCV RNA levels were
quantified for 1,279 patients at the Louisiana State University Health
Sciences Center; 28 of these patients were coinfected with HIV. HCV
loads were quantified by the Bayer branched-DNA assay with a lower
limit of detection of 0.2 Meq/ml. We compared the median HCV RNA levels
of for patients coinfected with HIV and HCV and patients infected only
with HCV who were in the same age range (23 to 55 years). The median
HCV load for the 28 patients coinfected with HCV and HIV (17.8 Meq/ml)
was significantly greater (P < 0.05) than that for
similarly aged patients infected only with HCV (6.1 Meq/ml). The HCV
load did not correlate with age or sex for either group of patients. A significant (R =
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.4.690-694.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Comparison of Hepatitis C Viral Loads in Patients
with or without Human Immunodeficiency Virus
0.4; P < 0.05)
negative correlation was observed between HCV load and CD4 count in the
coinfected group, for whom the CD4 counts at the time of HCV load
analysis ranged from 6 to 1,773/mm3. The increased HCV load
in patients coinfected with HCV and HIV compared to that in patients
infected only with HCV and the inverse relationship of the HCV load to
the CD4 count indicate that immunosuppression results in decreased
control of HCV replication. In addition, we report significantly higher
HCV loads among coinfected African Americans than Caucasians.
*
Corresponding author. Mailing address: Department of
Medicine, Section of Infectious Diseases, LSUHSC, 1501 Kings Highway, Shreveport, LA 71130. Phone: 318 675-5993. Fax: 318 675-5907. E-mail:
wchang{at}lsuhsc.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |